Granite Point Capital Management, L.P. - Q1 2019 holdings

$1.03 Billion is the total value of Granite Point Capital Management, L.P.'s 108 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .

 Value Shares↓ Weighting
SMH NewVANECK VECTORS ETF TRput$46,785,000440,000
+100.0%
4.53%
XBI NewSPDR SERIES TRUSTput$45,270,000500,000
+100.0%
4.38%
AAPL NewAPPLE INCput$37,990,000200,000
+100.0%
3.68%
XOP NewSPDR SERIES TRUSTcall$30,740,0001,000,000
+100.0%
2.98%
MJ NewETF MANAGERS TRput$23,641,000650,000
+100.0%
2.29%
TLRY NewTILRAY INCput$16,380,000250,000
+100.0%
1.58%
KRE NewSPDR SERIES TRUSTcall$15,402,000300,000
+100.0%
1.49%
DB NewDEUTSCHE BANK AGcall$12,180,0001,500,000
+100.0%
1.18%
TELL NewTELLURIAN INC NEWcall$10,080,000900,000
+100.0%
0.98%
GOOS NewCANADA GOOSE HOLDINGS INCcall$9,604,000200,000
+100.0%
0.93%
SIEN NewSIENTRA INC$7,550,000880,000
+100.0%
0.73%
ZEN NewZENDESK INCput$6,715,00079,000
+100.0%
0.65%
NewTILRAY INCdebt 5.000%10/0$5,810,0007,000,000
+100.0%
0.56%
SE NewSEA LTDsponsored ads$5,410,000230,000
+100.0%
0.52%
LULU NewLULULEMON ATHLETICA INC$4,588,00028,000
+100.0%
0.44%
CRSAU NewCRESCENT ACQUISITION CORPunit 99/99/9999$2,000,000200,000
+100.0%
0.19%
KWEB NewKRANESHARES TRcsi chi internet$1,870,00039,700
+100.0%
0.18%
MTNB NewMATINAS BIOPHARMA HLDGS INC$1,860,0001,706,134
+100.0%
0.18%
TAST NewCARROLS RESTAURANT GROUP INC$1,775,000178,000
+100.0%
0.17%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$1,642,0009,000
+100.0%
0.16%
AXGT NewAXOVANT SCIENCES LTD$1,374,0001,033,333
+100.0%
0.13%
PDD NewPINDUODUO INCsponsored ads$1,364,00055,000
+100.0%
0.13%
ECOR NewELECTROCORE INC$1,250,000178,571
+100.0%
0.12%
ON NewON SEMICONDUCTOR CORP$1,234,00060,000
+100.0%
0.12%
ARRY NewARRAY BIOPHARMA INC$1,219,00050,000
+100.0%
0.12%
EDU NewNEW ORIENTAL ED & TECH GRP Ispon adr$991,00011,000
+100.0%
0.10%
NewFINISAR CORPnote 0.500%12/1$982,0001,000,000
+100.0%
0.10%
BMY NewBRISTOL MYERS SQUIBB CO$954,00020,000
+100.0%
0.09%
VFF NewVILLAGE FARMS INTL INC$841,00060,000
+100.0%
0.08%
INNT NewINNOVATE BIOPHARMACEUTICLS I$828,000429,184
+100.0%
0.08%
CTRP NewCTRIP COM INTL LTDsponsored ads$812,00018,587
+100.0%
0.08%
FANH NewFANHUA INCput$788,00030,000
+100.0%
0.08%
YRD NewYIRENDAI LTDsponsored adr$760,00056,035
+100.0%
0.07%
OVID NewOVID THERAPEUTICS INC$740,000417,857
+100.0%
0.07%
WUBA New58 COM INCspon adr rep a$663,00010,100
+100.0%
0.06%
BIDU NewBAIDU INCspon adr rep a$659,0004,000
+100.0%
0.06%
EYPT NewEYEPOINT PHARMACEUTICALS INC$589,000329,000
+100.0%
0.06%
NewMAGNACHIP SEMICONDUCTOR SAnote 5.000% 3/0$567,000500,000
+100.0%
0.06%
ATNX NewATHENEX INC$490,00040,000
+100.0%
0.05%
OSTK NewOVERSTOCK COM INC DEL$456,00027,450
+100.0%
0.04%
LX NewLEXINFINTECH HLDGS LTDadr$420,00040,000
+100.0%
0.04%
ARLO NewARLO TECHNOLOGIES INC$366,00088,647
+100.0%
0.04%
STM NewSTMICROELECTRONICS N Vny registry$297,00020,000
+100.0%
0.03%
UXIN NewUXIN LTDads$303,00080,000
+100.0%
0.03%
BEDU NewBRIGHT SCHOLAR ED HLDGS LTDsponsored ads$207,00020,000
+100.0%
0.02%
SFUN NewFANG HLDGS LTDadr$166,000123,000
+100.0%
0.02%
ACMR NewACM RESEARCH INC$158,00010,240
+100.0%
0.02%
QD NewQUDIAN INCadr$152,00030,000
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
META PLATFORMS INC37Q1 20233.9%
AMAZON COM INC33Q1 20235.9%
ALIBABA GROUP HLDG LTD30Q1 20231.7%
TAL EDUCATION GROUP28Q4 20220.9%
ISHARES TR27Q2 202255.1%
ALPHABET INC25Q1 20232.7%
APPLE INC25Q1 20232.3%
AXOGEN INC24Q1 20222.5%
RINGCENTRAL INC24Q4 20220.7%
ADVANCED MICRO DEVICES INC22Q1 20238.5%

View Granite Point Capital Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
Granite Point Capital Management, L.P. Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Neuronetics, Inc.Sold outJanuary 26, 202200.0%
Sientra, Inc.February 12, 20212,396,0004.7%
MARINUS PHARMACEUTICALS INCJanuary 27, 20201,368,8111.6%

View Granite Point Capital Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-07
13F-HR2023-08-10
13F-HR2023-05-11
13F-HR2023-02-07
13F-HR2022-11-04
13F-HR2022-08-05
13F-HR2022-05-11
13F-HR2022-02-11
SC 13G/A2022-01-26
13F-HR2021-11-10

View Granite Point Capital Management, L.P.'s complete filings history.

Compare quarters

Export Granite Point Capital Management, L.P.'s holdings